The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

The active ingredient in Wegovy and Ozempic may reduce the risk of Alzheimer's disease for patients with type-2 diabetes, a ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) drug, and is the active agent in Ozempic and its weight-loss cousin, Wegovy.

Alzheimer's disease treatments aimed at activating liver proteins known to regulate cholesterol and lipid (fat) metabolism ...

CAMBRIDGE, Mass., Oct. 24, 2024Inc. (Nasdaq: BIIB) announced upcoming data presentations and programming at the Clinical Trials on Alzheimer's Disease (CTAD) annual conference, taking place October 29 ...